Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
2002 4
2003 5
2004 2
2005 3
2006 2
2007 5
2008 4
2009 3
2010 3
2011 5
2012 5
2013 4
2014 2
2015 4
2016 2
2017 1
2018 3
2019 3
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality.
Tamburini E, Dallatomasina A, Quartararo J, Cortelazzi B, Mangieri D, Lazzaretti M, Perris R. Tamburini E, et al. Among authors: perris r. FASEB J. 2019 Mar;33(3):3112-3128. doi: 10.1096/fj.201801670R. Epub 2018 Dec 14. FASEB J. 2019. PMID: 30550356 Review.
Methylation Dynamics of RASSF1A and Its Impact on Cancer.
Malpeli G, Innamorati G, Decimo I, Bencivenga M, Nwabo Kamdje AH, Perris R, Bassi C. Malpeli G, et al. Among authors: perris r. Cancers (Basel). 2019 Jul 9;11(7):959. doi: 10.3390/cancers11070959. Cancers (Basel). 2019. PMID: 31323949 Free PMC article. Review.
"Destemming" cancer stem cells.
Hill RP, Perris R. Hill RP, et al. Among authors: perris r. J Natl Cancer Inst. 2007 Oct 3;99(19):1435-40. doi: 10.1093/jnci/djm136. Epub 2007 Sep 25. J Natl Cancer Inst. 2007. PMID: 17895479 Review.
Theranostic impact of NG2/CSPG4 proteoglycan in cancer.
Nicolosi PA, Dallatomasina A, Perris R. Nicolosi PA, et al. Among authors: perris r. Theranostics. 2015 Feb 15;5(5):530-44. doi: 10.7150/thno.10824. eCollection 2015. Theranostics. 2015. PMID: 25767619 Free PMC article. Review.
Antithetic roles of proteoglycans in cancer.
Garusi E, Rossi S, Perris R. Garusi E, et al. Among authors: perris r. Cell Mol Life Sci. 2012 Feb;69(4):553-79. doi: 10.1007/s00018-011-0816-1. Epub 2011 Oct 2. Cell Mol Life Sci. 2012. PMID: 21964924 Review.
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.
Mazzera L, Abeltino M, Lombardi G, Cantoni AM, Jottini S, Corradi A, Ricca M, Rossetti E, Armando F, Peli A, Ferrari A, Martinelli G, Scupoli MT, Visco C, Bonifacio M, Ripamonti A, Gambacorti-Passerini C, Bonati A, Perris R, Lunghi P. Mazzera L, et al. Among authors: perris r. Leukemia. 2023 Aug;37(8):1671-1685. doi: 10.1038/s41375-023-01940-x. Epub 2023 Jun 29. Leukemia. 2023. PMID: 37386079 Free PMC article.
58 results